COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 79 filers reported holding COHERUS BIOSCIENCES INC in Q4 2015. The put-call ratio across all filers is 14.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $64,366 | -14.5% | 37,206 | +18.1% | 0.00% | – |
Q1 2024 | $75,299 | -77.2% | 31,506 | -68.2% | 0.00% | – |
Q4 2023 | $329,590 | +40.1% | 98,976 | +57.3% | 0.00% | – |
Q3 2023 | $235,261 | -88.9% | 62,904 | -87.3% | 0.00% | -100.0% |
Q2 2023 | $2,116,311 | +312.1% | 495,623 | +560.2% | 0.00% | +200.0% |
Q1 2023 | $513,527 | -19.1% | 75,077 | -6.3% | 0.00% | 0.0% |
Q4 2022 | $634,424 | -77.8% | 80,104 | -73.0% | 0.00% | -75.0% |
Q3 2022 | $2,855,275 | +30.7% | 297,115 | -1.5% | 0.00% | -33.3% |
Q2 2022 | $2,184,000 | +134.6% | 301,589 | +318.0% | 0.01% | +200.0% |
Q1 2022 | $931,000 | -14.0% | 72,142 | +6.5% | 0.00% | 0.0% |
Q4 2021 | $1,082,000 | -3.4% | 67,760 | -2.8% | 0.00% | 0.0% |
Q3 2021 | $1,120,000 | +18.4% | 69,710 | +2.0% | 0.00% | 0.0% |
Q2 2021 | $946,000 | -4.3% | 68,363 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $989,000 | +20.3% | 67,722 | +43.2% | 0.00% | 0.0% |
Q4 2020 | $822,000 | +27.2% | 47,280 | +34.3% | 0.00% | +100.0% |
Q3 2020 | $646,000 | +1.9% | 35,211 | -0.8% | 0.00% | 0.0% |
Q2 2020 | $634,000 | -14.3% | 35,493 | -22.3% | 0.00% | -50.0% |
Q1 2020 | $740,000 | -8.4% | 45,651 | +1.7% | 0.00% | 0.0% |
Q4 2019 | $808,000 | +64.9% | 44,866 | +85.7% | 0.00% | +100.0% |
Q3 2019 | $490,000 | -8.2% | 24,165 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $534,000 | +84.1% | 24,165 | +13.8% | 0.00% | 0.0% |
Q1 2019 | $290,000 | +44.3% | 21,230 | -4.4% | 0.00% | – |
Q4 2018 | $201,000 | -39.1% | 22,212 | +11.1% | 0.00% | -100.0% |
Q3 2018 | $330,000 | +26.9% | 19,992 | +7.7% | 0.00% | 0.0% |
Q2 2018 | $260,000 | +33.3% | 18,565 | +5.4% | 0.00% | – |
Q1 2018 | $195,000 | +25.8% | 17,607 | 0.0% | 0.00% | – |
Q4 2017 | $155,000 | -34.0% | 17,607 | 0.0% | 0.00% | -100.0% |
Q3 2017 | $235,000 | -7.1% | 17,607 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $253,000 | -10.3% | 17,607 | +32.2% | 0.00% | 0.0% |
Q1 2017 | $282,000 | -24.8% | 13,314 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $375,000 | +5.0% | 13,314 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $357,000 | +58.7% | 13,314 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $225,000 | +7.1% | 13,314 | +45.9% | 0.00% | 0.0% |
Q4 2015 | $210,000 | -35.8% | 9,128 | -19.4% | 0.00% | 0.0% |
Q2 2015 | $327,000 | – | 11,331 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,446,000 | 2.17% |
CM Management, LLC | 125,000 | $2,009,000 | 1.50% |
Bridge City Capital, LLC | 163,210 | $2,623,000 | 1.19% |
Perceptive Advisors | 4,779,387 | $76,805,000 | 1.12% |
Phocas Financial Corp. | 504,936 | $8,114,000 | 1.03% |
Redwood Investments, LLC | 716,531 | $11,515,000 | 0.96% |
Aristotle Capital Boston, LLC | 2,155,221 | $34,634,000 | 0.81% |
KNOTT DAVID M | 102,555 | $1,648,000 | 0.60% |
Zebra Capital Management LLC | 22,918 | $368,000 | 0.45% |
Temasek Holdings (Private) Ltd | 7,381,116 | $118,615,000 | 0.42% |